Venture capitalists are raising piles of cash to invest in healthcare — even as less of that cash is actually being put to work at startups.
U.S. healthcare venture investors are standing firm in the belief that innovation in the life sciences, coupled with falling valuations, will in time pay off. In the first quarter, these investors secured $6.8 billion, a pace that exceeds that of 2022, when $21.8 billion was raised for the entire year, according to Silicon Valley Bank, now a division of First Citizens Bank. The tallies include healthcare-only funds and healthcare allocations of diversified pools, The Wall Street Journal reports. Read more.
